Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial.

Vibeke StrandMark KosinskiChieh-I ChenGeorge JosephRegina Rendas-BaumNeil M H GrahamHubert van HoogstratenMartha BaylissChunpeng FanTom HuizingaMark C Genovese

Published in: Arthritis research & therapy (2016)

ClinicalTrials.gov. NCT01061736 . February 2, 2010.

Keyphrases

phase iii
patient reported outcomes
rheumatoid arthritis
open label
clinical trial
high dose
phase ii
double blind
placebo controlled
disease activity
study protocol
randomized controlled trial
systemic sclerosis